<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34732518</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2052-4439</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>BMJ open respiratory research</Title><ISOAbbreviation>BMJ Open Respir Res</ISOAbbreviation></Journal><ArticleTitle>Patient symptoms and experience following COVID-19: results from a UK-wide survey.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e001075</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjresp-2021-001075</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To investigate the experience of people who continue to be unwell after acute COVID-19, often referred to as 'long COVID', both in terms of their symptoms and their interactions with healthcare.</AbstractText><AbstractText Label="DESIGN">We conducted a mixed-methods analysis of responses to a survey accessed through a UK online post-COVID-19 support and information hub, between April and December 2020, about people's experiences after having acute COVID-19.</AbstractText><AbstractText Label="PARTICIPANTS">3290 respondents, 78% female, 92.1% white ethnicity and median age range 45-54 years; 12.7% had been hospitalised. 494(16.5%) completed the survey between 4 and 8 weeks of the onset of their symptoms, 641(21.4%) between 8 and 12 weeks and 1865 (62.1%) &gt;12 weeks after.</AbstractText><AbstractText Label="RESULTS">The ongoing symptoms most frequently reported were: breathing problems (92.1%), fatigue (83.3%), muscle weakness or joint stiffness (50.6%), sleep disturbances (46.2%), problems with mental abilities (45.9%), changes in mood, including anxiety and depression (43.1%) and cough (42.3%). Symptoms did not appear to be related to the severity of the acute illness or to the presence of pre-existing medical conditions. Analysis of free-text responses revealed three main themes: (1) experience of living with COVID-19: physical and psychological symptoms that fluctuate unpredictably; (2) interactions with healthcare that were unsatisfactory; (3) implications for the future: their own condition, society and the healthcare system, and the need for research CONCLUSION: Consideration of patient perspectives and experiences will assist in the planning of services to address problems persisting in people who remain symptomatic after the acute phase of COVID-19.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buttery</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philip</LastName><ForeName>Keir E J</ForeName><Initials>KEJ</Initials><Identifier Source="ORCID">0000-0001-9614-3580</Identifier><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Parris</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fallas</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Asthma UK and British Lung Foundation Partnership, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>West</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Asthma UK and British Lung Foundation Partnership, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cumella</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Asthma UK and British Lung Foundation Partnership, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Asthma UK and British Lung Foundation Partnership, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Asthma UK and British Lung Foundation Partnership, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quint</LastName><ForeName>Jennifer K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Respiratory Epidemiology, Occupational Medicine and Public Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polkey</LastName><ForeName>Michael I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hopkinson</LastName><ForeName>Nicholas S</ForeName><Initials>NS</Initials><Identifier Source="ORCID">0000-0003-3235-0454</Identifier><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK n.hopkinson@ic.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open Respir Res</MedlineTA><NlmUniqueID>101638061</NlmUniqueID><ISSNLinking>2052-4439</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>4</Day><Hour>5</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34732518</ArticleId><ArticleId IdType="pmc">PMC8572361</ArticleId><ArticleId IdType="doi">10.1136/bmjresp-2021-001075</ArticleId><ArticleId IdType="pii">8/1/e001075</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pollard CA, Morran MP, Nestor-Kalinoski AL. The COVID-19 pandemic: a global health crisis. Physiol Genomics 2020;52:549&#x2013;57. 10.1152/physiolgenomics.00089.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00089.2020</ArticleId><ArticleId IdType="pmc">PMC7686876</ArticleId><ArticleId IdType="pubmed">32991251</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip K, Cumella A, Farrington-Douglas J, et al. . Respiratory patient experience of measures to reduce risk of COVID-19: findings from a descriptive cross-sectional UK wide survey. BMJ Open 2020;10:e040951. 10.1136/bmjopen-2020-040951</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-040951</ArticleId><ArticleId IdType="pmc">PMC7482474</ArticleId><ArticleId IdType="pubmed">32912958</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip KEJ, Lonergan B, Cumella A, et al. . COVID-19 related concerns of people with long-term respiratory conditions: a qualitative study. BMC Pulm Med 2020;20:319. 10.1186/s12890-020-01363-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-020-01363-9</ArticleId><ArticleId IdType="pmc">PMC7724437</ArticleId><ArticleId IdType="pubmed">33298023</ArticleId></ArticleIdList></Reference><Reference><Citation>Struyf T, Deeks JJ, Dinnes J, et al. . Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev 2020;7:CD013665. 10.1002/14651858.CD013665</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013665</ArticleId><ArticleId IdType="pmc">PMC7386785</ArticleId><ArticleId IdType="pubmed">32633856</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239&#x2013;42. 10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkinson NS, Rossi N, El-Sayed Moustafa J, et al. . Current smoking and COVID-19 risk: results from a population symptom APP in over 2.4 million people. Thorax 2021;76:714&#x2013;22. 10.1136/thoraxjnl-2020-216422</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216422</ArticleId><ArticleId IdType="pubmed">33402392</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Valdes AM, Freidin MB, et al. . Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med 2020;26:1037&#x2013;40. 10.1038/s41591-020-0916-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0916-2</ArticleId><ArticleId IdType="pmc">PMC7751267</ArticleId><ArticleId IdType="pubmed">32393804</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkinson NS, Jenkins G, Hart N. COVID-19 and what comes after? Thorax 2021;76:324&#x2013;5. 10.1136/thoraxjnl-2020-216226</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216226</ArticleId><ArticleId IdType="pubmed">33589513</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall J, Myall K, Lam JL, et al. . Identifying patients at risk of post-discharge complications related to COVID-19 infection. Thorax 2021;76:408&#x2013;11. 10.1136/thoraxjnl-2020-215861</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215861</ArticleId><ArticleId IdType="pubmed">33542090</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. . 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax 2021;76:396&#x2013;8. 10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, et al. . Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 2021;76:399&#x2013;401. 10.1136/thoraxjnl-2020-216086</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AS, Wong AW, Hague CJ, et al. . A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax 2021;76:402&#x2013;4. 10.1136/thoraxjnl-2020-216308</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216308</ArticleId><ArticleId IdType="pubmed">33273023</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O'Brien K, et al. . Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc 2021;18:997&#x2013;1003. 10.1513/AnnalsATS.202009-1175OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202009-1175OC</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, et al. . Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax 2021;76:405&#x2013;7. 10.1136/thoraxjnl-2020-216377</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>NIHR Themed Review: Living with Covid19 - Second review 2021.</Citation></Reference><Reference><Citation>Sivan M, Taylor S. Nice guideline on long covid. BMJ 2020;371:m4938. 10.1136/bmj.m4938</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4938</ArticleId><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE . COVID-19 rapid guideline: managing the long-term effects of COVID-19. NG188, 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, et al. . Management of post-acute covid-19 in primary care. BMJ 2020;370:m3026. 10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77&#x2013;101. 10.1191/1478088706qp063oa</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/1478088706qp063oa</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. . More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv 2021:2021.01.27.21250617. 10.1101/2021.01.27.21250617</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AJ, MacKenna B, Inglesby P, et al. . Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. Br J Gen Pract 2021:2021.2005.2006.21256755. 10.3399/BJGP.2021.0301</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2021.0301</ArticleId><ArticleId IdType="pmc">PMC8340730</ArticleId><ArticleId IdType="pubmed">34340970</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, et al. . Persistent symptoms 3&#x2005;months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res 2020;6:00542-2020&#x2013;2020. 10.1183/23120541.00542-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorna R, MacDermott N, Rayner C, et al. . Long COVID guidelines need to reflect lived experience. Lancet 2021;397:455&#x2013;7. 10.1016/S0140-6736(20)32705-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32705-7</ArticleId><ArticleId IdType="pmc">PMC7755576</ArticleId><ArticleId IdType="pubmed">33357467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, et al. . Persistent symptoms after Covid-19: qualitative study of 114 "long Covid" patients and draft quality principles for services. BMC Health Serv Res 2020;20:1144. 10.1186/s12913-020-06001-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockfield S, Chhabra R, Robertson M, et al. . Links between iron and lipids: implications in some major human diseases. Pharmaceuticals 2018;11:113. 10.3390/ph11040113</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph11040113</ArticleId><ArticleId IdType="pmc">PMC6315991</ArticleId><ArticleId IdType="pubmed">30360386</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip K, Gaduzo S, Rogers J, et al. . Patient experience of COPD care: outcomes from the British lung Foundation patient Passport. BMJ Open Respir Res 2019;6:e000478. 10.1136/bmjresp-2019-000478</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2019-000478</ArticleId><ArticleId IdType="pmc">PMC6797266</ArticleId><ArticleId IdType="pubmed">31673369</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Haneuse SJPA, Rubenfeld GD, et al. . Reporting clinical studies affected by the COVID-19 pandemic: guidelines for authors. JAMA Netw Open 2021;4:e2036155. 10.1001/jamanetworkopen.2020.36155</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36155</ArticleId><ArticleId IdType="pubmed">33443576</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Covid-19: What do we know about "long covid"? BMJ 2020;370:m2815. 10.1136/bmj.m2815</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2815</ArticleId><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made long Covid. Soc Sci Med 2021;268:113426. 10.1016/j.socscimed.2020.113426</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker-Davies RM, O'Sullivan O, Senaratne KPP, et al. . The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med 2020;54:949&#x2013;59. 10.1136/bjsports-2020-102596</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2020-102596</ArticleId><ArticleId IdType="pmc">PMC7418628</ArticleId><ArticleId IdType="pubmed">32475821</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Long covid: who calls on countries to offer patients more rehabilitation. BMJ 2021;372:n405. 10.1136/bmj.n405</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n405</ArticleId><ArticleId IdType="pubmed">33568362</ArticleId></ArticleIdList></Reference><Reference><Citation>Polgar O, Aljishi M, Barker RE, et al. . Digital habits of PR service-users: implications for home-based interventions during the COVID-19 pandemic. Chron Respir Dis 2020;17:1479973120936685. 10.1177/1479973120936685</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1479973120936685</ArticleId><ArticleId IdType="pmc">PMC7328358</ArticleId><ArticleId IdType="pubmed">32602361</ArticleId></ArticleIdList></Reference><Reference><Citation>Puchner B, Sahanic S, Kirchmair R, et al. . Beneficial effects of multi-disciplinary rehabilitation in postacute COVID-19: an observational cohort study. Eur J Phys Rehabil Med 2021;57:189&#x2013;98. 10.23736/S1973-9087.21.06549-7</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S1973-9087.21.06549-7</ArticleId><ArticleId IdType="pubmed">33448756</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom CI, Drake TM, Docherty AB, et al. . Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC who clinical characterisation protocol UK. Lancet Respir Med 2021;9:699&#x2013;711. 10.1016/S2213-2600(21)00013-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00013-8</ArticleId><ArticleId IdType="pmc">PMC8241313</ArticleId><ArticleId IdType="pubmed">33676593</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>